Gritstone bio, Inc. (GRTS)

Gritstone bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-138.49	-119.69	-75.08	-105.31	-94.43
Depreciation & Amortization	21.65	15.69	14.4	14.16	11.13
Share-Based Compensation	11.62	12.56	10.55	7.11	5.3
Other Operating Activities	-16.43	-24.51	-0.55	-5.05	-7
Operating Cash Flow	-121.65	-115.95	-50.68	-89.1	-85.01
Capital Expenditures	-4.57	-5.87	-5.7	-3.52	-16.17
Change in Investments	106.91	-7.09	-112.85	69.46	32.01
Investing Cash Flow	102.34	-12.96	-118.55	65.95	15.84
Share Issuance / Repurchase	8.93	65.51	117.21	135.91	75.2
Debt Issued / Paid	17.13	18.48	-8.45	-0.1	-0.81
Other Financing Activities	-0.95	-0.89	-	-	-
Financing Cash Flow	25.12	83.1	108.76	135.8	74.4
Net Cash Flow	5.81	-45.81	-60.47	112.65	5.23
Free Cash Flow	-126.22	-121.82	-56.38	-92.62	-101.18
Free Cash Flow Margin	-772.27%	-610.77%	-116.93%	-2294.20%	-2318.08%
Free Cash Flow Per Share	-1.09	-1.34	-0.71	-2.45	-3.02

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).